OpenAI Researcher to Launch Drug Discovery Startup
TechCrunch AI · rss · 2026-07-15
TechCrunch AI reports that OpenAI researcher Miles Wang is raising funds for an AI drug discovery startup, targeting a valuation of around $2 billion.
The report also notes that Lightspeed is in talks to lead the funding round; however, negotiations are ongoing, making this an unconfirmed deal rumor.
More from Venture
- Beth Kindig says her Q3 AI stocks report flags 5 winners up more than 100% YTD — Beth_Kindig · 2026-07-22
- AI’s economic forecasts are split by nearly a quadrillion dollars by 2035 — bittingthembits · 2026-07-22
- LLM Agent Trader pairs backtesting with model-generated trading signals — tom_doerr · 2026-07-22
- OpenRouter spend data suggests frontier models still capture most paying usage — thedealdirector · 2026-07-21
- AI is collapsing startup and operating costs as U.S. business formation hits a record — sanjaykalra · 2026-07-21
- Soxton lands on investors’ 2026 legal-startup watchlist with $2.5M raised — ashleymayer · 2026-07-21